[1]ChemicalandPharmaceuticalBulletin,1984,vol.32,p.2100-2110
[1]CurrentPatentAssignee:OTSUKAHOLDINGSCOLTD-US4760064,1988,A
[1]CurrentPatentAssignee:OTSUKAHOLDINGSCOLTD-US4415572,1983,A
[1]CurrentPatentAssignee:OTSUKAHOLDINGSCOLTD-US4415572,1983,A
[1]CurrentPatentAssignee:OTSUKAHOLDINGSCOLTD-US4415572,1983,A
Title: Animal models of cardiorenal syndrome: a review.
Journal: Heart failure reviews 20120501
Title: Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure.
Journal: PloS one 20120101
Title: Red cell distribution width: a novel marker of activity in inflammatory bowel disease.
Journal: Gut and liver 20111201
Title: Are there differences in acute phase inflammation markers regarding the type of heart failure?
Journal: Heart international 20110929
Title: New predictive models of heart failure mortality using time-series measurements and ensemble models.
Journal: Circulation. Heart failure 20110701
Title: Effect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failure.
Journal: Cardiology research and practice 20110101
Title: Design, synthesis and biological evaluation of 6-(benzyloxy)-4-methylquinolin-2(1H)-one derivatives as PDE3 inhibitors.
Journal: Bioorganic & medicinal chemistry 20100115
Title: Effect of levosimendan in experimental verapamil-induced myocardial depression.
Journal: Scandinavian journal of trauma, resuscitation and emergency medicine 20100101
Title: β-Adrenoceptor activation depresses brain inflammation and is neuroprotective in lipopolysaccharide-induced sensitization to oxygen-glucose deprivation in organotypic hippocampal slices.
Journal: Journal of neuroinflammation 20100101
Title: A novel approach to improve cardiac performance: cardiac myosin activators.
Journal: Heart failure reviews 20091201
Title: Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials.
Journal: European heart journal 20091201
Title: Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.
Journal: Heart failure reviews 20091201
Title: Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities.
Journal: PloS one 20090101
Title: Vesnarinone represses the fibrotic changes in murine lung injury induced by bleomycin.
Journal: International journal of biological sciences 20090101
Title: Comparative value of simple inflammatory markers in the prediction of left ventricular systolic dysfunction in postacute coronary syndrome patients.
Journal: Mediators of inflammation 20090101
Title: Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.
Journal: PloS one 20090101
Title: Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells.
Journal: Molecular cancer 20090101
Title: Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders.
Journal: Cardiovascular diabetology 20090101
Title: In silico risk assessment for drug-induction of cardiac arrhythmia.
Journal: Progress in biophysics and molecular biology 20080901
Title: Placebo effect-adjusted assessment of quality of life in placebo-controlled clinical trials.
Journal: Statistics in medicine 20080430
Title: Bunched, the Drosophila homolog of the mammalian tumor suppressor TSC-22, promotes cellular growth.
Journal: BMC developmental biology 20080101
Title: Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model.
Journal: American journal of physiology. Heart and circulatory physiology 20070701
Title: Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials.
Journal: Journal of the American College of Cardiology 20070403
Title: Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity.
Journal: Journal of applied toxicology : JAT 20070101
Title: Effects of promyelocytic leukemia zinc finger protein on the proliferation of cultured human corneal endothelial cells.
Journal: Molecular vision 20070101
Title: Association of cytokines with endothelium dependent flow mediated vasodilation (FMD) of systemic arteries in patients with non-ischemic cardiomyopathy.
Journal: Cardiovascular ultrasound 20070101
Title: Differentiation-inducing therapy for solid tumors.
Journal: Current pharmaceutical design 20060101
Title: Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?
Journal: Respiratory research 20060101
Title: Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Journal: International journal of oncology 20051201
Title: A comparison of the covalent binding of clozapine, procainamide, and vesnarinone to human neutrophils in vitro and rat tissues in vitro and in vivo.
Journal: Chemical research in toxicology 20050901
Title: Treating critical illness: the importance of first doing no harm.
Journal: PLoS medicine 20050601
Title: Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis.
Journal: Arthritis research & therapy 20050101
Title: Frequent downregulation of 14-3-3 sigma protein and hypermethylation of 14-3-3 sigma gene in salivary gland adenoid cystic carcinoma.
Journal: British journal of cancer 20040913
Title: TSC-22 (TGF-beta stimulated clone-22): a novel molecular target for differentiation-inducing therapy in salivary gland cancer.
Journal: Current cancer drug targets 20040901
Title: Comparison of kinetic properties of quinidine and dofetilide block of HERG channels.
Journal: European journal of pharmacology 20040616
Title: New positive inotropic agents in the treatment of left ventricular dysfunction.
Journal: Italian heart journal : official journal of the Italian Federation of Cardiology 20040601
Title: Models of dilated cardiomyopathy in small animals and novel positive inotropic therapies.
Journal: Annals of the New York Academy of Sciences 20040501
Title: The best of times, the worst of times: the wealth and poverty of heart failure pharmacotherapies: is there a role for vesnarinone?
Journal: Drug safety 20040101
Title: Clinical characteristics of vesnarinone.
Journal: Drug safety 20040101
Title: Precautions for use and adverse effects of vesnarinone: potential mechanisms and future therapies.
Journal: Drug safety 20040101
Title: Optimising outcomes in end-stage heart failure: differences in therapeutic responses between diverse ethnic groups.
Journal: Drug safety 20040101
Title: Vesnarinone-mediated alterations of gene expression in cardiac fibroblasts from aortic regurgitant hearts.
Journal: American journal of therapeutics 20040101
Title: Extended application of an LC-MS/MS method for the analysis of vesnarinone and its metabolites in human urine and dialysate fluid.
Journal: Journal of pharmaceutical and biomedical analysis 20031124
Title: Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Journal: Bioorganic & medicinal chemistry letters 20030818
Title: Vesnarinone: a differentiation-inducing anti-cancer drug.
Journal: Anti-cancer drugs 20030701
Title: Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain.
Journal: Molecular pharmacology 20030501
Title: [Inotropic agents].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20030501
Title: Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
Journal: The Medical clinics of North America 20030301
Title: Transcriptional activation of cyclin-dependent kinase inhibitor, p21waf1 gene by treatment with a differentiation inducing agent, vesnarinone in a human salivary gland cancer cell line.
Journal: Journal of experimental & clinical cancer research : CR 20030301
Title: Management of congestive heart failure: a gender gap may still exist. Observations from a contemporary cohort.
Journal: BMC cardiovascular disorders 20030101
Title: Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line.
Journal: British journal of cancer 20021021
Title: Inotropic agents and immune modulation.
Journal: Cardiovascular drugs and therapy 20020501
Title: Vesnarinone causes oxidative damage by inhibiting catalase function through ceramide action in myeloid cell apoptosis.
Journal: Molecular pharmacology 20020301
Title: Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested.
Journal: Leukemia research 20020201
Title: Item response models for joint analysis of quality of life and survival.
Journal: Statistics in medicine 20020115
Title: Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone).
Journal: Oncology reports 20020101
Title: Open channel block of HERG K(+) channels by vesnarinone.
Journal: Molecular pharmacology 20010801
Title: Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial.
Journal: Chest 20010801
Title: The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure.
Journal: International journal of cardiology 20010801
Title: Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).
Journal: Circulation 20010424
Title: Carvedilol and vesnarinone: new antiarrhythmic approach in heart failure therapy.
Journal: Acta pharmacologica Sinica 20010301
Title: OPC-8212, a quinoline derivative, counteracts the reduction in type III collagen mRNA due to lipopolysaccharides in cultured rat cardiac fibroblasts.
Journal: Japanese heart journal 20010101
Title: Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 4th communication: influence on experimentally induced ventricular arrhythmia in dogs.
Journal: Arzneimittel-Forschung 19990501
Title: Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
Journal: Journal of molecular and cellular cardiology 19961201
Title: Vesnarinone inhibits production of HIV-1 in cultured cells.
Journal: Biochemical and biophysical research communications 19930930
Title: Inhibitors of cyclic AMP phosphodiesterase. 2. Structural variations of N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro- 2-oxoimidazo[2,1-b]quinazolin-7-yl)-oxy]butyramide (RS-82856).
Journal: Journal of medicinal chemistry 19870201
Title: In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
Journal: Arzneimittel-Forschung 19840101
